- Home
- TMDX vs NGD Comparison
TMDX vs NGD Comparison
Compare TMDX & NGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMDX
- NGD
- Stock Information
- Founded
- TMDX 1998
- NGD N/A
- Country
- TMDX United States
- NGD Canada
- Employees
- TMDX N/A
- NGD N/A
- Industry
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- NGD
- Sector
- TMDX Health Care
- NGD
- Exchange
- TMDX Nasdaq
- NGD Nasdaq
- Market Cap
- TMDX 3.9B
- NGD 3.9B
- IPO Year
- TMDX 2019
- NGD 2004
- Fundamental
- Price
- TMDX $114.30
- NGD $7.17
- Analyst Decision
- TMDX Buy
- NGD Buy
- Analyst Count
- TMDX 11
- NGD 2
- Target Price
- TMDX $130.73
- NGD $8.75
- AVG Volume (30 Days)
- TMDX 1.0M
- NGD 27.3M
- Earning Date
- TMDX 10-29-2025
- NGD 10-28-2025
- Dividend Yield
- TMDX N/A
- NGD N/A
- EPS Growth
- TMDX 170.70
- NGD 1232.42
- EPS
- TMDX 2.54
- NGD 0.31
- Revenue
- TMDX $566,354,000.00
- NGD $1,242,200,000.00
- Revenue This Year
- TMDX $38.84
- NGD $57.60
- Revenue Next Year
- TMDX $20.46
- NGD $59.57
- P/E Ratio
- TMDX $45.35
- NGD $22.74
- Revenue Growth
- TMDX 41.20
- NGD 44.19
- 52 Week Low
- TMDX $55.00
- NGD $2.43
- 52 Week High
- TMDX $145.50
- NGD $7.75
- Technical
- Relative Strength Index (RSI)
- TMDX 40.85
- NGD 53.81
- Support Level
- TMDX $115.21
- NGD $6.85
- Resistance Level
- TMDX $125.57
- NGD $7.75
- Average True Range (ATR)
- TMDX 7.65
- NGD 0.40
- MACD
- TMDX -1.72
- NGD 0.03
- Stochastic Oscillator
- TMDX 12.41
- NGD 63.32
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About NGD New Gold Inc.
New Gold Inc participates in the development and operation of intermediate mining properties. The company has a portfolio of two primary assets which are also its operating segments: the Rainy River Mine and the New Afton Mine in Canada. The company also owns the Cerro San Pedro Mine in Mexico. The company derives revenue from the sale of gold, copper, and silver.